Ali Mohammad Javed, Ayyar Anuradha, Motukupally Swapna R, Sharma Savitri, Naik Milind N
Dacryology Service, L.V.Prasad Eye Institute, Hyderabad 34, India.
Jhaveri Microbiology Center, L.V.Prasad Eye Institute, Hyderabad 34, India.
J Ophthalmic Inflamm Infect. 2014 Oct 9;4:27. doi: 10.1186/s12348-014-0027-7. eCollection 2014.
The aims of the study are to assess the prevalence of bacteremia during dacryocystorhinostomy (DCR) and to assess whether there is a need for post-operative prophylaxis. Prospective interventional study of 52 consecutive dacryocystorhinostomy performed in 50 patients over a period of 1 year from 2013 to 2014. Blood was drawn under strict aseptic conditions during two separate time points: fashioning of the nasal mucosal and creation of lacrimal sac flaps. The blood was inoculated into two blood culture bottles: the dual media as well as Columbia broth. Following withdrawal of blood, all patients received an intraoperative single dose of a cephalosporin antibiotic. Clean cases of primary acquired nasolacrimal duct obstructions (PANDO) without any sac discharge upon marsupialization (22%, 11/50) were not prescribed routine post-operative prophylaxis, whereas the remaining were prescribed oral antibiotics for 5 days.
The mean age of patients was 41 years (range, 4-61 years). The most common diagnosis (70%, 35/50) was primary acquired nasolacrimal duct obstruction. Acute dacryocystitis was noted in 12% (6/50). External DCR was performed in 65% (34/52) and endoscopic DCR in 35% (18/52) of the cases. All the blood cultures were uniformly negative both in terms of abnormal physical changes in media as well subcultures; 22% (11/50) did not receive post-operative antibiotic prophylaxis. None of the patients developed any signs of wound infections. The anatomical and functional success rate was achieved in 98%.
This study did not find any intraoperative bacteremia during dacryocystorhinostomy and that none had wound infection irrespective of post-operative prophylaxis.
本研究的目的是评估泪囊鼻腔吻合术(DCR)期间菌血症的发生率,并评估是否需要术后预防。对2013年至2014年期间50例患者连续进行的52例泪囊鼻腔吻合术进行前瞻性干预研究。在两个不同时间点严格无菌条件下采血:鼻黏膜塑形和泪囊瓣制作时。血液接种到两个血培养瓶中:双相培养基和哥伦比亚肉汤。采血后,所有患者术中接受单剂量头孢菌素抗生素。对于一期获得性鼻泪管阻塞(PANDO)且造袋术后无泪囊分泌物的清洁病例(22%,11/50),未常规给予术后预防用药,而其余患者给予口服抗生素5天。
患者的平均年龄为41岁(范围4 - 61岁)。最常见的诊断(70%,35/50)是一期获得性鼻泪管阻塞。12%(6/50)患者有急性泪囊炎。65%(34/52)的病例采用外路泪囊鼻腔吻合术,35%(18/52)采用内镜下泪囊鼻腔吻合术。所有血培养在培养基的异常物理变化和传代培养方面均为阴性;22%(11/50)患者未接受术后抗生素预防。所有患者均未出现伤口感染迹象。解剖和功能成功率达98%。
本研究未发现泪囊鼻腔吻合术期间有任何术中菌血症,且无论术后是否预防,均无伤口感染发生。